ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 58 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $70,000 | -45.3% | 64,273 | -37.2% | 0.00% | – |
Q1 2022 | $128,000 | -69.2% | 102,321 | -60.6% | 0.00% | – |
Q4 2021 | $416,000 | -38.5% | 259,856 | +25.2% | 0.00% | – |
Q3 2021 | $676,000 | +113.9% | 207,569 | +315.1% | 0.00% | – |
Q2 2021 | $316,000 | +134.1% | 50,007 | -21.6% | 0.00% | – |
Q1 2021 | $135,000 | +159.6% | 63,770 | +199.3% | 0.00% | – |
Q3 2020 | $52,000 | – | 21,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
Ergoteles LLC | 514,600 | $561,000 | 0.02% |
Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
Spire Wealth Management | 100,300 | $109,000 | 0.00% |
Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |